Abstract: Provided are a method and an apparatus for implementing batch extraction of human anatomical feature parameters. The method includes: obtaining a to-be-measured sample; generating an average model; calculating a point correspondence of a spatial location formed by the average model and each to-be-measured sample; measuring each to-be-measured sample on the average model; and outputting feature parameter data of each to-be-measured sample in batch. Calculation time is reduced by combining feature point extraction with affine transformation, and corresponding points are calculated through a non-rigid registration method to achieve batch and quick measurement.

Abstract: A tree or plant protection mat is provided, comprising: a top layer, having a first perimeter edge; a water-permeable bottom layer, having a second perimeter edge affixed either directly to the first perimeter edge, or indirectly to the first perimeter edge via an intervening sidewall; and a water-absorbing and releasing center layer disposed between the top and bottom layers, and comprising a section having superabsorbent particles and a section not having superabsorbent particles. Other mats and methods are provided.

Abstract: Provided are a method and apparatus for evaluating anatomical adaptation of an implantable orthopedic medical device. The method includes: obtaining an anatomical adaptation region of a to-be-evaluated bone with the implantable orthopedic medical device; determining a baseline of the anatomical adaptation region and a baseline of the implantable orthopedic medical device for position registration, and conducting the position registration for the anatomical adaptation region and the implantable orthopedic medical device based on the baselines; and evaluating adhesion of the to-be-evaluated bone to the implantable orthopedic medical device by calculating a distance from each point on an inner curved surface of the implantable orthopedic medical device to the anatomical adaptation region.

Abstract: A solution circulation concentrating device with high solar energy utilization efficiency and a concentrating method using the same are provided, and relate to the technical field of solution concentration equipment. The device includes a concentrated solution collecting tray, an evaporator, a rotation driving device, a liquid inlet pipe, a liquid outlet pipe, a liquid storage tank, a filter tank, and a rainwater discharge pipe. The concentrated solution collecting tray is rotatably connected with the evaporator. The evaporator is connected with the rotation driving device. The rotation driving device is configured for driving the evaporator to rotate. The liquid inlet pipe and the liquid outlet pipe are arranged at the concentrated solution collecting tray. The liquid inlet pipe is configured to pass through the evaporator.

Abstract: The present invention relates to chimeric papilloma virus L1 proteins and polynucleotides encoding thereof, and also to HPV virus-like particles and the preparation methods thereof. Said chimeric papilloma virus L1 protein comprises an N-terminal fragment derived from L1 protein of the first papilloma virus type, said N-terminal fragment maintains the immunogenicity of the L1 protein of the corresponding type of HPV; and a C-terminal fragment derived from L1 protein of the second papilloma virus type, said L1 protein of the second papilloma virus type has a better expression level and a better solubility compared to the L1 proteins of other HPV types; wherein said chimeric papilloma virus L1 proteins have the immunogenicity of the L1 proteins of the corresponding HPV types. Said chimeric papilloma virus L proteins have better expression amount and solubility for mass production of vaccines.

Abstract: The present invention relates to chimeric papilloma virus L1 proteins and polynucleotides encoding thereof, and also to HPV virus-like particles and the preparation methods thereof. Said chimeric papilloma virus L1 protein comprises an N-terminal fragment derived from L1 protein of the first papilloma virus type, said N-terminal fragment maintains the immunogenicity of the L1 protein of the corresponding type of HPV; and a C-terminal fragment derived from L1 protein of the second papilloma virus type, said L1 protein of the second papilloma virus type has a better expression level and a better solubility compared to the L1 proteins of other HPV types; wherein said chimeric papilloma virus L1 proteins have the immunogenicity of the L1 proteins of the corresponding HPV types. Said chimeric papilloma virus L proteins have better expression amount and solubility for mass production of vaccines.

Abstract: Provided is an efficient preparation method of a bimetallic seamless composite pipe, and belongs to the technical field of steel pipe manufacture. The efficient preparation method of the bimetallic seamless composite pipe includes following steps: sheathing a base pipe blank on a cladding pipe blank to obtain a composite pipe blank, and carrying out a stress relief annealing treatment on the composite pipe blank, where the base pipe blank and the cladding pipe blank are made of different materials; heating the composite pipe blank after the stress relief annealing treatment to a hot working window temperature, and sheathing on a core rod of an extrusion cylinder after an insulation treatment, and then extruding along an axial direction of the extrusion cylinder to obtain a bimetallic seamless composite pipe.

Abstract: A pedal fault diagnosis method and apparatus for a vehicle are provided, including: detecting whether a driver seat is in an unmanned state; collecting an actual zero position voltage of a pedal when the driver seat is in the unmanned state; and then determining, based on the actual zero position voltage, whether a zero position fault exists on the pedal. The apparatus may update a set value of a zero position voltage in a vehicle controller based on the actual zero position voltage that is collected when the driver seat is in the unmanned state, and may be applied to the fields of assisted driving and automatic driving. Vehicle control safety can be improved by using the actual zero position voltage that is collected when the driver seat is in the unmanned state.

Abstract: Provided by the present disclosure is an ultrasonic phased array-based in-situ imaging method for melt flow in injection molding. The ultrasonic phased array is used for the detection of an injection molding process for the first time, and an effective dynamic monitoring imaging method for a melt front position is developed. A melt flow process in a mold cavity is dynamically monitored by collecting an FMC (Full matrix capture) dataset online. A mapping relationship between an incident angle and a target pixel point is established to rapidly determine time delay of each point in a measurement target region, and a melt bottom image is acquired using TFM (Total focusing method) imaging conditions, from which the melt front can be localized. The provided method is high in measurement accuracy, short in imaging time, and capable of effectively improving imaging efficiency of online measurement.

Abstract: The present invention relates to chimeric papilloma virus L1 proteins and polynucleotides encoding thereof, and also to HPV virus-like particles and the preparation methods thereof. Said chimeric papilloma virus L1 protein comprises an N-terminal fragment derived from L1 protein of the first papilloma virus type, said N-terminal fragment maintains the immunogenicity of the L1 protein of the corresponding type of HPV; and a C-terminal fragment derived from L1 protein of the second papilloma virus type, said L1 protein of the second papilloma virus type has a better expression level and a better solubility compared to the L1 proteins of other HPV types; wherein said chimeric papilloma virus L1 proteins have the immunogenicity of the L1 proteins of the corresponding HPV types. Said chimeric papilloma virus L proteins have better expression amount and solubility for mass production of vaccines.

Abstract: There is provided a computer implemented method. The method provides a generation of a proof of existence data structures. The method comprising: (i) receiving a request comprising a data reveal path, the data reveal path referencing a node of interest within an input hierarchical data structure (ii) obtaining the input hierarchical data structure comprising an input root node and a plurality of input nodes, wherein each of the input nodes within the input hierarchical data structure have an associated value, and (iii) generating an output hierarchical data structure based on the data reveal path and the input hierarchical data structure, wherein the output hierarchical data structure comprises a plurality of output nodes. There is also provided a method for verification of the proof of existence.

Abstract: An imaging device is provided. The imaging device includes: one or more imaging sources; and a plurality of detectors combined by joining, the plurality of detectors being configured to receive one or more imaging beams emitted by the one or more imaging sources.

Abstract: A compound having a BCL-XL protein degradation function as shown in Formula I and a use thereof in preparation of a drug for diseases associated with BCL-XL activity.

Abstract: A connector includes a housing having a slot and a first glue filling cavity communicated with the slot, a flexible circuit board inserted into the housing through the slot, and a first sealant formed by a glue filled into the first glue filling cavity and the slot. The first sealant is bonded with the flexible circuit board and the housing to seal between the flexible circuit board and the housing.

Abstract: The present invention relates to chimeric papilloma virus L1 proteins and polynucleotides encoding thereof, and also to HPV virus-like particles and the preparation methods thereof. Said chimeric papilloma virus L1 protein comprises an N-terminal fragment derived from L1 protein of the first papilloma virus type, said N-terminal fragment maintains the immunogenicity of the L1 protein of the corresponding type of HPV; and a C-terminal fragment derived from L1 protein of the second papilloma virus type, said L1 protein of the second papilloma virus type has a better expression level and a better solubility compared to the L1 proteins of other HPV types; wherein said chimeric papilloma virus L1 proteins have the immunogenicity of the L1 proteins of the corresponding HPV types. Said chimeric papilloma virus L proteins have better expression amount and solubility for mass production of vaccines.

Abstract: The present invention relates to chimeric papilloma virus L1 proteins and polynucleotides encoding thereof, and also to HPV virus-like particles and the preparation methods thereof. Said chimeric papilloma virus L1 protein comprises an N-terminal fragment derived from L1 protein of the first papilloma virus type, said N-terminal fragment maintains the immunogenicity of the L1 protein of the corresponding type of HPV; and a C-terminal fragment derived from L1 protein of the second papilloma virus type, said L1 protein of the second papilloma virus type has a better expression level and a better solubility compared to the L1 proteins of other HPV types; wherein said chimeric papilloma virus L1 proteins have the immunogenicity of the L1 proteins of the corresponding HPV types. Said chimeric papilloma virus L proteins have better expression amount and solubility for mass production of vaccines.

Abstract: A computer-implemented method for tracking, on a blockchain, at least two clients interacting with an asset, wherein the blockchain comprises a set of transactions associated with the asset, and a set of transactions associated with each client. The asset tracking comprising receiving an asset interaction event request comprising data based on at least two clients associated with an asset interaction event and data indicative of the asset, generating an event transaction based on a reference to the set of transactions associated with the asset and references to the sets of transactions associated with the at least two clients, and submitting the event transaction to the blockchain.

Abstract: There is provided a phase shifter having a phase shift region and a peripheral region, and including a first substrate, a second substrate and a dielectric layer between such two substrates; the first substrate includes a first dielectric substrate, a first electrode and a first auxiliary structure; the second substrate includes a second dielectric substrate, a second electrode and a second auxiliary structure; the phase shift region includes overlapping regions; the first electrode and the second electrode are located in the phase shift region, and have orthographic projections, on the first dielectric substrate, overlapped at least partially in the overlapping regions; the first auxiliary structure is in the peripheral region and on a side, close to the dielectric layer, of the first dielectric substrate; the second auxiliary structure is in the peripheral region and on a side, close to the dielectric layer, of the second dielectric substrate.

Abstract: Point cloud coding methods, an encoder, and a decoder are provided. The method includes the following. Morton codes for a point cloud are obtained according to geometry information of the point cloud after geometry decoding is completed and the geometry information is reconstructed. A value of K is determined according to a distribution of the point cloud, where K is a positive integer, where K is a positive integer. The point cloud is determined as an input point cloud of an iteration. Morton codes for an input point cloud of an i-th iteration are right shifted by K bits according to a number of points in the input point cloud of the i-th iteration. An i-th level of detail (LOD) layer is formed with a point selected after the Morton codes are shifted. Color information is decoded according to the LOD layer.

Abstract: The present technology provides for facilitating efficient identification of relevant metrics. In one embodiment, a set of candidate metrics for which to determine relevance to a user is identified. For each candidate metric, a set of distribution parameters is determined, including a first distribution parameter based on implicit positive feedback associated with the metric and usage data associated with the metric and a second distribution parameter based on the usage data associated with the metric. Such usage data can efficiently facilitate identifying relevance even with an absence of negative feedback. Using the set of distribution parameters, a corresponding distribution is generated. Each distribution can then be sampled to identify a relevance score for each candidate metric indicating an extent of relevance of the corresponding metric. Based on the relevance scores for each candidate metric, a candidate metric is designated as relevant to the user.